Affordable Access

deepdyve-link
Publisher Website

A Prospective Randomized Double-Blind Study Evaluating UP165 and S-Adenosyl-l-Methionine on Depression, Anxiety and Psychological Well-Being.

Authors
  • Kalman, Douglas S1
  • Feldman, Samantha2
  • Vazquez, Rafeal Rivas3
  • Krieger, Diane R4
  • 1 Miami Research Associates, Endocrinology and Nutrition Department, 6141 Sunset Drive, Suite 301, Miami, FL 33143, USA. [email protected]
  • 2 Miami Research Associates, Endocrinology and Nutrition Department, 6141 Sunset Drive, Suite 301, Miami, FL 33143, USA. [email protected]
  • 3 Miami Research Associates, Neurosciences Department, 6141 Sunset Drive, Suite 301, Miami, FL 33143, USA. [email protected]
  • 4 Miami Research Associates, Endocrinology and Nutrition Department, 6141 Sunset Drive, Suite 301, Miami, FL 33143, USA. [email protected]
Type
Published Article
Journal
Foods
Publisher
MDPI AG
Publication Date
May 08, 2015
Volume
4
Issue
2
Pages
130–139
Identifiers
DOI: 10.3390/foods4020130
PMID: 28231193
Source
Medline
Keywords
License
Unknown

Abstract

The primary objective of this pilot clinical trial was to evaluate the effects of UP165 (derived from Zea mays L., commonly known as corn) over time. The secondary objective was the comparison for outcomes versusS-adenosyl-methionine (SAM-e). Subjects with mild depression or anxiety were given the Beck Depression Inventory second edition (BDI-II), the Beck Anxiety Inventory (BAI), and the Schwartz Outcome Scale (SOS-10). Forty-two subjects (21-65 years old) were randomized to eight-weeks of supplementation with UP165 or SAM-e with questionnaires being administered at randomization, week four and eight. Those receiving UP165 achieved significant reduction from baseline at weeks four and eight, respectively for the BDI-II, as well as a trend for reduction in BAI at week four and significance at week eight. There was a trend for improvement on the SOS at week four and significance at week eight. SAM-e demonstrated a trend for improvement on the BDI-II by week eight over the UP165 with no differences between the two for the BAI or the SOS. Overall, this study indicates that there may be benefit to UP165 for mood enhancement in those with mild depression or anxiety. Randomized placebo comparator trials appear warranted.

Report this publication

Statistics

Seen <100 times